Efg Capital International Corp. Charles River Laboratories International, Inc. Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
A detailed history of Efg Capital International Corp. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Efg Capital International Corp. holds 1,092 shares of CRL stock, worth $205,252. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,092Holding current value
$205,252% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$393 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$359 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$257 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...